MRFF Rapid Applied Research Translation Projects
MACH has received MRFF Rapid Applied Research Translation (RART) funding over three separate rounds (known as rounds 1, 2.1, 2.2).
This funding, specifically allocated to NHMRC-accredited Advanced Health Research Translation Centres and Centres for Innovation in Regional Health (Translation Centres) has enabled MACH to fund:
- Transformative Translational Research – that delivers scalable solutions to health service problems and directly benefits patients, and
- National System Level Initiatives – where the Translation Centres collaborate with each other to deliver improvements in health services and systems sustainability by addressing national systems level priorities.
The table below includes the MACH Transformative Translational Research projects funded through RART rounds 1, 2.1 and 2.2. For further details regarding National System Level Initiatives please refer to the Australian Health Research Alliance website.
Note: From 2021 (round 3) the RART program moved to open competition. Successful MACH-partner led projects from round 3 are not listed below.
|RART Round||Lead Investigator||Project Title||Lead Organisation||MACH Partners||Funds Received|
|1||Prof Ingrid Scheffer AO||Developing precision medicine for the developmental and epileptic encephalopathies||The University of Melbourne||Austin Health; Florey Institute of Neuroscience and Mental Health; Royal Children's Hospital; Walter and Eliza Hall Institute||$500,000|
|1||Prof Andrea Maier||Enhancing Muscle POWER in Geriatric Rehabilitation: EMPOWER-GR||The University of Melbourne||Melbourne Health; Northern Health; Western Health||$500,000|
|1||Prof Mingguang He||Integration of retinal photography and artificial intelligence to build opportunistic screening services in primary care settings||The University of Melbourne||Centre for Eye Research Australia; Royal Victorian Eye and Ear Hospital; St Vincent's Hospital Melbourne||$300,000|
|1||Prof Jo Douglass||Melbourne Thunderstorm Epidemic of Asthma: Solving the puzzle||The University of Melbourne||Austin Health; Melbourne Health; Northern Health; Walter and Eliza Hall Institute; Western Health||$700,000|
|2.1/2.2||A/Prof Andrew Bivard||Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (TASTEa)||The University of Melbourne||Austin Health; Florey Institute of Neuroscience and Mental Health; Melbourne Health; St Vincent’s Hospital Melbourne; Western Health||$267,000|
|2.1/2.2||A/Prof Luke Burchill||Closing the gap on Indigenous cardiovascular (CV) health: Improving community outcomes through high impact policy relevant research.||The University of Melbourne||Austin Health; Melbourne Health; Northern Health; Peter MacCallum Cancer Centre||$275,000|
|2.1/2.2||A/Prof Adam Deane||Liberal glUcose Control in critically Ill patient with pre-existing type 2 Diabetes (LUCID): a phase IIB multi-centre parallel group randomised clinical trial||The University of Melbourne||Austin Health; Melbourne Health; Northern Health; Peter MacCallum Cancer Centre; St Vincent’s Hospital Melbourne; Royal Women’s Hospital; Western Health||$255,000|
|2.1/2.2||Prof Gustavo Duque||Integrating Osteoporosis in Primary Care: The Osteoporosis Risk and Management (ORMA) Project||The University of Melbourne||Austin Health; Western Health||$325,000|
|2.1/2.2||Prof Harriet Hiscock||Improving the care of children with frequent asthma admissions through parnterships with hospitals, GPs, and families.||Murdoch Children’s Research Institute||Northern Health; Royal Children's Hospital; The University of Melbourne||$300,000|
|2.1/2.2||A/Prof Craig Nelson||Future Health Today Project-Co-design of Prototype||The University of Melbourne||Western Health (including primary care affiliates)||$324,600|
|2.2||Prof Amy Brodtmann||Establishing a stroke biobank to examine protein and genetic biomarkers for post-stroke cognitive decline in the Post Ischaemic Stroke Cardiovascular Exercise Study (PISCES)||The University of Melbourne||Austin Health; Florey Institute; Melbourne Health; Western Health||$275,000|
|2.2||Prof David Castle||Evaluating the impact of a psychological intervention to reduce the severe stress and psychological morbidity of people with chronic kidney disease: The Kidney Optimal Health Program (KOHP): Stage 2||St Vincent's Hospital Melbourne||Austin Health; The University of Melbourne||$275,000|
|2.2||Prof Elif Ekinci||Can flash glucose monitoring improve blood glucose control in Indigenous Australians with type 2 diabetes?||The University of Melbourne||Austin Health; Melbourne Health; Northern Health; St Vincent's Health Melbourne||$275,000|
|2.2||Prof Nicola Lautenschlager||Physical activity guidelines implementation via information and communication technology for vulnerable older adults with poor cognitive and mental health living in the community||The University of Melbourne||Melbourne Health; Northern Health; St Vincent's Hospital Melbourne||$275,000|
|2.2||Dr Ashley McAllister||Clinical and community service provision for people with disabilities: Investigating the perspectives of the health care workforce and their clients||The University of Melbourne||Melbourne Health, Northern Health||$275,000|
|2.2||Prof Jeannette Milgrom AM||Clinical Decision Support Integrated with e-Screening for Postnatal Depression||Austin Health (Parent-Infant Research Institute)||University of Melbourne||$270,000|
|2.2||Prof Dinah Reddihough||Hips on Track: A state-wide approach to preventing hip dislocation for young people with cerebral palsy||Murdoch Children’s Research Institute||Royal Children's Hospital; St Vincent's Hospital Melbourne; University of Melbourne; Western Health||$275,000|
|2.2||Prof Dennis Velakoulis||Clinical utility of plasma neurofilament light chain in the diagnostic screening of psychiatric and neurological disorders: An “ESR” for the brain?||Melbourne Health||Austin Health; Florey Institute; St Vincent’s Hospital Melbourne; University of Melbourne; Western Health||$275,000|
|2.2||Prof Vicki Anderson||Reducing persisting symptoms following child concussion a randomised controlled clinical trial||Murdoch Children’s Research Institute||Austin Health; Florey Institute; Royal Children's Hospital; University of Melbourne||$275,000|
|2.2||Care of the Ageing Committee||Expertise mapping project||MACH Care of the Ageing Committee - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|
|2.2||Data Driven Healthcare Improvement Committee||Consolidation of record linkage algorithms in Victoria and beyond||MACH Data Driven Healthcare Improvement Committee - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|
|2.2||Clinical Trials and Research Facilitation Committee||Research Capacity building through complex trial design symposia||MACH Clinical Trials and Research Facilitation Committee - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|
|2.2||Education and Workforce Planning Committee||The next big thing: Optimising the role of interdisciplinary students in hospital outpatient clinics: scribing and closing the loop of communication with primary care.||MACH Education and Workforce Planning Committee - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|
|2.2||Women’s and Newborn Health Committee||Find and Follow: scoping the data capture, reporting and follow-up of (i) pregnancies complicated by congenital abnormalities, (ii) health and development among ‘high risk’ newborns.||MACH Women's and Newborn Health Committee - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|
|2.2||Aboriginal Leadership Group||Dynamic consent as a new approach for engaging people in health research and upholding data sovereignty – Victorian Aboriginal perspectives.||MACH Aboriginal Leadership Group - funding administered by the University of Melbourne||Relevant MACH partners are represented by the Committee||$80,000|